Enhancing Capital LLC purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,000 shares of the company’s stock, valued at approximately $325,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC bought a new stake in shares of Clorox during the third quarter worth about $27,000. Continuum Advisory LLC increased its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares in the last quarter. Asset Planning Inc bought a new stake in shares of Clorox during the fourth quarter worth about $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in shares of Clorox during the fourth quarter worth about $36,000. 78.53% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
CLX has been the subject of several recent research reports. Evercore ISI boosted their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Wells Fargo & Company boosted their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Barclays boosted their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Clorox presently has an average rating of “Hold” and an average price target of $159.62.
Clorox Stock Down 2.5 %
CLX opened at $144.70 on Wednesday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The stock has a market cap of $17.83 billion, a price-to-earnings ratio of 39.54, a PEG ratio of 2.62 and a beta of 0.45. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company’s 50-day moving average price is $153.71 and its two-hundred day moving average price is $160.08.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business earned $2.16 EPS. As a group, equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.37%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is currently 133.33%.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- What is a support level?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 3 Must-Own Stocks to Build Wealth This Decade
- Top Stocks Investing in 5G Technology
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.